According to the business intelligence report titled ‘Asia Pacific Healthcare AI Market Size By Application, Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027’, available with Market Study Report, Asia Pacific healthcare AI market is anticipated to accrue revenues worth USD 4.1 billion by 2027.
 

AI capabilities to enhance patient care quality, rapid developments in big data analytics, and widespread application are key factors spurring Asia Pacific healthcare AI market expansion. Moreover, increasing adoption of healthcare AI solutions due to shortage of skilled healthcare professionals will spur industry growth as well.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3855712/
 

The report also cites that increasing research & development activities, government initiatives & funds and launch of innovative products will aid Asia Pacific healthcare AI industry proliferation.
 

While surging geriatric populace will aid market growth in the forthcoming years, factors such as difficulty in deployment, and high initial cost are poised to act as a challenge.
 

Based on application scope, the industry is bifurcated into therapy planning, drug discovery, hospital workflow, virtual assistants, wearables, and others.
 

Considering the geographical landscape, China held a significant portion of Asia Pacific healthcare AI market share in the past year due to technological advancements and the ongoing digital revolution in the healthcare segment. Presence of leading players and research & development activities will also propel industry expansion in China.
 

Meanwhile, the Japan healthcare AI market is projected to expand at 47.8% CAGR between 2021-2027 and will be valued at USD 1.2 billion by 2027. Surging geriatric population, developments in healthcare infrastructure and growing expenditure in the field are key factors contributing to this proliferation.
 

Key players profiled in the report are AiCure LLC, Atomwise Inc, Apixio Inc., Butterfly Network Inc., Enlitic Inc., Cyrcadia Health Inc., iCarbonX, Watson Health (IBM), Insilico Medicine, Modernizing Medicine Inc., Nvidia Corporation, OmeCare Inc., SOPHiA Genetics, Sense.ly Inc., Welltok Inc., Johnson & Johnson, and Zebra Medical Vision Limited.